AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Nov 5, 2012
30016_dirs_2012-11-05_beeaa26e-cd94-4a07-84e0-2255e94c1526.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-11-01
Reporting Person: Williams Michael J PhD (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-01 | Common Stock | M | 2806 | $28.6550 | Acquired | 10402 | Direct |
| 2012-11-01 | Common Stock | S | 2806 | $96.0192 | Disposed | 7596 | Direct |
| 2012-11-01 | Common Stock | S | 131 | $96.00 | Disposed | 7465 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-01 | Non-Qualified Stock Option (right to buy) | $28.6550 | M | 2806 | Disposed | 2015-02-02 | Common Stock (2806) | Direct |
Footnotes
F1: Includes 57 shares and 51 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 06/30/2012 and 09/30/2012, respectively.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $96.00 to $96.09, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F3: Grant of options to buy shares of common stock becomes exercisable as to 2,720 shares on 02/03/2006, 2,720 on 02/03/2007, 2,720 on 02/03/2008, and the remaining 1,646 shares on 02/03/2009.